277 related articles for article (PubMed ID: 23823830)
21. Antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary artery stenting: safety and efficacy data from a single center.
Rubboli A; Colletta M; Sangiorgio P; Di Pasquale G
Ital Heart J; 2004 Dec; 5(12):919-25. PubMed ID: 15706997
[TBL] [Abstract][Full Text] [Related]
22. Antithrombotic Regimens for Patients Taking Oral Anticoagulation After Coronary Intervention: A Meta-analysis of 16 Clinical Trials and 9,185 Patients.
Gao XF; Chen Y; Fan ZG; Jiang XM; Wang ZM; Li B; Mao WX; Zhang JJ; Chen SL
Clin Cardiol; 2015 Aug; 38(8):499-509. PubMed ID: 25963316
[TBL] [Abstract][Full Text] [Related]
23. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
Manzano-Fernández S; Pastor FJ; Marín F; Cambronero F; Caro C; Pascual-Figal DA; Garrido IP; Pinar E; Valdés M; Lip GYH
Chest; 2008 Sep; 134(3):559-567. PubMed ID: 18641090
[TBL] [Abstract][Full Text] [Related]
24. Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation.
Sarafoff N; Martischnig A; Wealer J; Mayer K; Mehilli J; Sibbing D; Kastrati A
J Am Coll Cardiol; 2013 May; 61(20):2060-6. PubMed ID: 23524219
[TBL] [Abstract][Full Text] [Related]
25. Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting.
Caballero L; Ruiz-Nodar JM; Marín F; Roldán V; Hurtado JA; Valencia J; Manzano-Fernandez S; Sogorb F; Valdes M; Lip GY
Age Ageing; 2013 Jan; 42(1):70-5. PubMed ID: 22983982
[TBL] [Abstract][Full Text] [Related]
26. A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Sullivan AE; Nanna MG; Rao SV; Cantrell S; Gibson CM; Verheugt FWA; Peterson ED; Lopes RD; Alexander JH; Granger CB; Yee MK; Kong DF
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E102-E109. PubMed ID: 31713326
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
Rossini R; Musumeci G; Lettieri C; Molfese M; Mihalcsik L; Mantovani P; Sirbu V; Bass TA; Della Rovere F; Gavazzi A; Angiolillo DJ
Am J Cardiol; 2008 Dec; 102(12):1618-23. PubMed ID: 19064015
[TBL] [Abstract][Full Text] [Related]
28. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy.
Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED
Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442
[TBL] [Abstract][Full Text] [Related]
29. An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI).
Gibson CM; Mehran R; Bode C; Halperin J; Verheugt F; Wildgoose P; van Eickels M; Lip GY; Cohen M; Husted S; Peterson E; Fox K
Am Heart J; 2015 Apr; 169(4):472-8.e5. PubMed ID: 25819853
[TBL] [Abstract][Full Text] [Related]
30. Triple antithrombotic therapy is the independent predictor for the occurrence of major bleeding complications: analysis of percent time in therapeutic range.
Naruse Y; Sato A; Hoshi T; Takeyasu N; Kakefuda Y; Ishibashi M; Misaki M; Abe D; Aonuma K;
Circ Cardiovasc Interv; 2013 Aug; 6(4):444-51. PubMed ID: 23941857
[TBL] [Abstract][Full Text] [Related]
31. Dual antiplatelet therapy and antithrombotic treatment in patients with acute coronary syndrome--does everyday medical practice reflects current recommendations? A pilot study.
Pelc-Nowicka A; Bryniarski L; Mirek-Bryniarska E; Zabojszcz M
Kardiol Pol; 2009 Dec; 67(12):1335-41. PubMed ID: 20054764
[TBL] [Abstract][Full Text] [Related]
32. Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.
Cassese S; Byrne RA; Tada T; King LA; Kastrati A
Eur Heart J; 2012 Dec; 33(24):3078-87. PubMed ID: 23091199
[TBL] [Abstract][Full Text] [Related]
33. Antithrombotic therapy in the anticoagulated patient undergoing percutaneous coronary intervention with coronary stenting.
Jhagroe DA; Janssen PW; Ten Berg JM
Curr Opin Cardiol; 2015 Jul; 30(4):319-24. PubMed ID: 26049376
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet therapy in patients with anticoagulants undergoing percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]).
Gilard M; Blanchard D; Helft G; Carrier D; Eltchaninoff H; Belle L; Finet G; Le Breton H; Boschat J;
Am J Cardiol; 2009 Aug; 104(3):338-42. PubMed ID: 19616664
[TBL] [Abstract][Full Text] [Related]
35. Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation.
Ho KW; Ivanov J; Freixa X; Overgaard CB; Osten MD; Ing D; Horlick E; Mackie K; Seidelin PH; Džavík V
Can J Cardiol; 2013 Feb; 29(2):213-8. PubMed ID: 23089528
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of triple-antiplatelet therapy after percutaneous coronary intervention: a meta-analysis.
Zhang Y; Tang HQ; Li J; Fu ZX
Chin Med J (Engl); 2013; 126(9):1750-4. PubMed ID: 23652062
[TBL] [Abstract][Full Text] [Related]
37. A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry.
Rubboli A; Bolognese L; Di Pasquale G; Galvani M; La Vecchia L; Maggioni AP
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):200-3. PubMed ID: 19377385
[TBL] [Abstract][Full Text] [Related]
38. Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting.
Rubboli A; Colletta M; Valencia J; Capecchi A; Franco N; Zanolla L; La Vecchia L; Piovaccari G; Di Pasquale G;
J Interv Cardiol; 2009 Aug; 22(4):390-7. PubMed ID: 19453820
[TBL] [Abstract][Full Text] [Related]
39. In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry.
Rubboli A; Sciahbasi A; Briguori C; Saia F; Palmieri C; Moroni LA; Calabrò P; Leone AM; Franco N; Valgimigli M; Varani E; Santi M; Pasqualini P; Capecchi A; Piccalò G; Margheri M; di Pasquale G; Galvani M; Bolognese L; Gonzini L; Maggioni AP;
J Invasive Cardiol; 2013 Apr; 25(4):170-6. PubMed ID: 23549489
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.
Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Kim DK; Seol SH; Kim DI; Cho KI; Kim BH; Park YH; Je HG; Jeong YH; Kim WJ; Lee JY; Lee SW
Cardiology; 2012; 122(3):133-43. PubMed ID: 22832424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
